-
Loading metrics
Rate of reclassification of HER2-equivocal breast cancer cases to HER2-negative per the 2018 ASCO/CAP guidelines and response of HER2-equivocal cases to anti-HER2 therapy
- James Crespo,
- Hongxia Sun,
- Jimin Wu,
- Qing-Qing Ding,
- Guilin Tang,
- Melissa K. Robinson,
- Hui Chen,
- Aysegul A. Sahin,
- Bora Lim
x
- Published: November 12, 2020
- https://doi.org/10.1371/journal.pone.0241775